AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06409585 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 68Ga-FAPI or 18F-AlF-FAPI cardiac PET-MR
Description: 200MBq of the above named radiotracer will be administered for PET-MR
Study NCT06245044 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scenario #2
Description: MI help will be displayed concurrently with the filled and reference images.
Study NCT06409585 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiogram
Description: Echocardiogram at baseline and 1 year follow-up
Study NCT04255849 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
Description: Gardasil-9 HPV vaccine
Study NCT04255849 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline Placebo
Description: Saline Placebo
Study NCT06017427 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Submission of several questionnaires (Quality of Life and clinical scores) at three time points: before initiation of Dupilumab, after 6 months of Dupilumab treatment, and 6 months after stopping Dupilumab treatment
Study NCT05676008 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Microdosing of mindfulness
Description: The intervention consists of two parts: 1) four structured training sessions offered as online synchronous classes, and 2) self-microdosing of mindfulness activities in everyday life.
Study NCT04983940 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jatenzo
Description: 237 mg soft gel capsule taken twice a day by mouth with food.
Study NCT06482606 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Flickering Checkerboard Stimulation
Description: This visual stimulation is a succession of alternating black and white squares on a small monitor in the scanner, the black and white checkerboard creates the effect of flickering lights.
Study NCT06482606 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Flickering Checkerboard Stimulation
Description: This visual stimulation is a succession of alternating black and white squares on a small monitor in the scanner, the black and white checkerboard creates the effect of flickering lights.
Study NCT06099158 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HeartLogic
Description: HeartLogic alerts will be managed according to a standardized alert management guide to ensure uniform reactions to HeartLogic alerts.
Study NCT06409585 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac MRI
Description: Cardiac MRI at 1 year
Study NCT05350176 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: Probiotic capsules will be composed of 10 billion CFU of Lactobacillus plantarum.
Study NCT04989166 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Nano-curcumin
Description: Nano-curcumin soft gels
Study NCT05350176 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsules containing dextrose (1 capsule per day)
Study NCT04989166 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05618431 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: NIPT
Description: This research aims to develop and validate a new method for non-invasive prenatal testing
Study NCT06682650 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NPT-PLA
Description: NPT-PLA was developed and initially tested in 5 European countries in the EU-funded RESTORE study. PLA Participatory Learning in Action is a set of participatory research techniques in which participants use democratic processes to identify key actions needed to achieve a specific goal e.g. implementation of a tested decision making tool such as I2; and prioritize which of these need to be acted upon first and subsequently (in which order). Normalization Process Theory (NPT) is combined with PLA to help implementation teams using PLA to assess organization capacity and readiness to enact the selected action steps vis-a-vis NPT constructs, iteratively. These are coherence does everyone understand what needs to be done?; Cognitive participation Does everyone who needs to act 'buy in' to take action; collective action Is everyone who needs to act taking steps to make the change?'; and reflexive monitoring After the step has been taken, has it had the desired impact on the goal?
Study NCT06682650 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Quality Improvement
Description: Usual quality improvement includes principles of continuous quality improvement, such as Plan-Do-Study-Act cycles, to implement a specific goal. In this study, 'usual QI' methods already in use in 'active comparator' arm will be documented during the baseline assessment of clinical workflows in clinics assigned to that arm; and will be provided with a 'preset protocol' to implement the study shared decision-making tool (I2). Processes that implementation teams in these clinics use to achieve implementation will be documented.
Study NCT06199830 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: positive bronchial provocation test
Description: Patients were asked to inhale gradually increasing doses of methacholine (0.9% saline, 0.078, 0.312, 1.125 and 2.504 mg), and FEV1 was measured after each inhalation. This test was stopped until a reducing in baseline FEV1 of 20%.
Study NCT05522400 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) and human computer interaction system
Description: The experimental group used VR technology and human-computer interaction system for exercise, while the control group used traditional exercise program
Study NCT06421441 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self Management Skills Training
Description: Nursing students will be given self-management skills training for a total of 12 hours, two days a week, two hours a day (60 min. + 60 min.) for three weeks.
Study NCT06570499 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Implant impression
Description: definitive impressions on implants
Study NCT06570031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-4578
Description: Specified dose on specified days
Study NCT06570031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: letrozole
Description: Specified dose on specified days
Study NCT06570031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Specified dose on specified days
Study NCT06570031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: abemaciclib
Description: Specified dose on specified days
Study NCT03841474 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psychiatric treatment with sertraline
Description: Psychiatric treatment with sertraline (range from 50 mg/day to 200mg/day according to clinical appearance) of newly recognized depression in patients after PCI
Study NCT03841474 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psychiatric treatment with escitalopram
Description: Psychiatric treatment with escitalopram (range from 10 mg/day to 20 mg/day according to clinical appearance) of newly recognized depression in patients after PCI
Study NCT05420467 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel
Description: 75 mg/m2, d1, q3w,6 cycles
Study NCT06684106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 500 mg
Description: UDCA together with statin in eligible participants
Study NCT06684106 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo together with statin in ASCVD patients
Study NCT05420467 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: AUC 6, d1, q3w,6 cycles
Study NCT05420467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC 6, d1, q3w,6 cycles
Study NCT05420467 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trastuzumab
Description: starting dose 8 mg/kg, maintenance dose 6 mg/kg, d1, q3w,6 cycles
Study NCT05420467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: starting dose 8 mg/kg, maintenance dose 6 mg/kg, d1, q3w,6 cycles
Study NCT05420467 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pertuzumab
Description: starting dose of 840 mg, maintenance dose of 420 mg, d1, q3w ,6 cycles
Study NCT05420467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pertuzumab
Description: starting dose of 840 mg, maintenance dose of 420 mg, d1, q3w ,6 cycles
Study NCT05420467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: 220 mg/m2, d1, q3w,6 cycles
Study NCT06695650 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mandala Coloring
Description: Students in the intervention group will be provided with mandala templates and coloring materials. They will be asked to color for 15 minutes twice a week over a two-month period
Study NCT06701721 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THN391 MAD
Description: Route of administration- IVT injection
Study NCT06703242 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Health promotion for mothers of children with ADHD in the ultra-orthodox community
Description: The intervention will consist of 3 modules with six sessions. Mothers will gain knowledge in topics related to understanding the ADHD health condition and its biological origins, optimal and recommended treatment options, school management techniques, and the importance of taking care of their own health.
Study NCT06710392 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Enzyme Cocktail A
Description: Enzyme cocktail A in the form of a capsule with a daily dose of 275mg taken 3 times a day for 4 weeks.
Study NCT06710392 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Enzyme Cocktail B
Description: Enzyme cocktail B in the form of a capsule with a daily dose of 50mg taken 3 times a day for 4 weeks.
Study NCT06710392 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo A
Description: Placebo A matching investigational product A given 3 times a day for 4 weeks.
Study NCT06710392 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo B
Description: Placebo B matching investigational product B given 3 times a day for 4 weeks.
Study NCT06708468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The intervention includes 12-day personalized exercise program set in a rehabilitation center, followed by a three-month digital intervention and then a second 12-day personalized exercise program in a rehabilitation center.
Study NCT06708468 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual care includes appointments at hospitals and in the community health system according to what has been recommended to that individual
Study NCT06709742 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gross Motor Function Measure-88 Based Therapy
Description: Children will be assessed initially by using GMFM-88 and selecting specific items for individuals according to his/her needs with the help of experts and family. At least 3 items will be selected for each subject in which they score less such that 0, 1 or 2. Training based on those specific items will be given to the children. This is goal-oriented training in which, according to the needs of children training will be provided.
Study NCT05420467 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epirubicin
Description: 90 mg/m2, d1, q3w ,4 cycles ,followed by docetaxel
Study NCT06707285 — intervention group
Intervention type: DEVICE
Intervention: MRI
Description: 1.5T siemens
Study NCT06708585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: progressive relaxation exercises and training
Description: Considering the high incidence of cesarean section and the prevalence of anxiety and fear as psychological symptoms, providing comfort and pain support to women is of great importance. Therefore, the effect of progressive relaxation exercise and education before cesarean section surgery on care outcomes will be determined.
Study NCT06710171 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counseling
Description: The intervention consists of using a theory-informed approach to user-centered brief counselling about PrEP uptake, designed specifically to help busy front-line providers in public health, sexual health and primary care settings advance clients along the PrEP cascade (specifically, supporting clients who meet evidence-based criteria for PrEP in accepting provider recommendations to use it) and provide linkage to care for related conditions.~The intervention will be delivered to GBM through participating healthcare providers who would have completed an online training designed by the research team.
Study NCT06710171 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: List of resources
Description: This list includes webpages which contain generic information about GBMs sexual health, PrEP, mental health, information about province-wide info lines for the general public about sexual health and/or educational resources for providers.
Study NCT06710171 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: List of resources
Description: This list includes webpages which contain generic information about GBMs sexual health, PrEP, mental health, information about province-wide info lines for the general public about sexual health and/or educational resources for providers.
Study NCT06708078 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Follow-up according to the Canhope allied health support program
Description: The Canhope allied health support program consists in:~* providing information tailored to patients' needs, with a dedicated time for patients to ask questions, obtain answers tailored to their needs, and be aware of the resources available to them;~* organizing peer-patient focus groups.~And aims at:~* reducing anxiety and improving patients' quality of life;~* better taking into account the impact of the announcement of intracranial Aneurysm, and to provide them with specific support.~* managing the emotional consequences of the announcement and the uncertainty of living with an intracranial Aneurysm.
Study NCT06709638 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Placebo Comparator
Study NCT06709638 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zhilong Huoxue Tongyu capsule
Description: Zhilong Huoxue Tongyu capsule
Study NCT06709105 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotape
Description: The application was performed using 5 cm x 5 m kinesio tape material. After preparing the standing patient in terms of clothing and skin readiness, the patient was asked to lean forward. To adhere the tape to the right paravertebral region, the lower end of the tape was first adhered 7 cm below the sacroiliac joint at the level of the paravertebral muscles. Then, while the patient was leaning forward, a slight rotation to the left was requested, and in this position, the tape was adhered upwards along the paravertebral muscles without any tension. When applying the tape to the left paravertebral region, the same procedure was mirrored as on the right, with the tape again applied without any tension. The third tape was applied while the patient was standing upright and leaning slightly forward, placed over the sacroiliac joints and parallel to the floor, stretching the tape by 25%.
Study NCT06709105 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham (no implant)
Description: Sham Kinesio taping was applied to the patients in the control group. In this sham protocol, Kinesio bands were attached between the 12th rib on both sides and the corresponding sacroiliac joint, passing over the paravertebral muscles without employing any specific banding technique. The third tape was adhered between both sacroiliac joints, also without any adhesive technique. Patients were inquired about any discomfort and informed that the tapes would remain in place until the second session.
Study NCT06707753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AL-001
Description: Administered via suprachoroidal space injection.
Study NCT06684327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-paclitaxel Injection
Description: Participant will receive albumin-paclitaxel 260mg/m2 d1, isocyclophosphamide 1500mg/m2 d2-5, and cisplatin 25mg/m2 d2-5 every 21 days until disease progression, intolerable toxicity, or full 6 cycles of treatment, whichever occurs first.
Study NCT06710236 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hearing instrument
Description: Conventional, daily wear hearing instruments will be used in this study.
Study NCT06709716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quadratus Lumborum Block (QLB)
Description: Pre-operative quadratus lumborum block with liposomal bupivacaine
Study NCT06709716 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Quadratus lumborum block
Description: Pre-operative quadratus lumborum block with saline
Study NCT06709716 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Local Anesthetic Solution
Description: Intraoperative injection of 0.25% bupivacaine at each incision site
Study NCT06709716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Local Anesthetic Solution
Description: Intraoperative injection of saline at each incision site.
Study NCT06708351 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive standard care
Study NCT06708351 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Promotion and Education
Description: Receive instructions on how to use HPV self-testing kit
Study NCT06708351 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: HPV Self-Collection
Description: Undergo HPV self-collection
Study NCT06708351 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Text Message-Based Navigation Intervention
Description: Receive text messages for HPV testing results and triage and treatment reminders
Study NCT06709365 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tibiotalar calcaneal fusion by hindfoot
Description: Hindfoot nail for ankle fusion
Study NCT05308459 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Data-driven health promotion at Vocational Education and Training schools (Data Health VET)
Description: The intervention consists of the following steps:~1. A local health profile is conducted among all students~2. Results are shortly hereafter presented and discussed with all student and staff, and the school decide what health problem they will work with during the next year~3. A participatory group model process based on a dynamic systems approach is conducted to develop sustainable and system changing activities to address the chosen health problem~4. The activities are implemented~5. A new health profile is conducted to a) evaluate the effects of the implemented activities and to b) determine if a new health problem warrant focus and new activities are needed (the process repeats itself).
Study NCT06745375 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: contact lens wear
Description: participants wear two different powered contact lenses (one with actual power, and one +/- 2.00Ds) contact lenses. No 2nd arm
Study NCT06744842 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: genicular nerve block
Description: genicular nerve block
Study NCT06744842 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: isometric exercise
Study NCT06744842 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: isometric exercise
Study NCT06736327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKB500
Description: The administration route of SKB500 is intravenous infusion, with a dosing frequency of Q3W.
Study NCT06744738 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharmacist led behavioral change technique
Description: The intervention was developed based on the behavior change technique taxonomy (v1). This intervention was designed to improve adherence to all therapeutic aspects of hemodialysis patients, including the dialysis program, medications, diet, and fluids. Additionally, the effect of the pharmacist intervention on physiological indices (serum potassium, total calcium, phosphate, IDWG, and hemoglobin) was examined.~The program was explicitly created for implementation in an actual setting, ensuring that the time allocation for participants and facilitators (the party responsible for conducting the PL-BCT) remained reasonable in most contexts.~The BCT components were developed after the identification and coding of the BCTs from previous interventional studies that contain behavioral components and result in positive effects on one or more hemodialysis patients' adherence domains toward their therapeutic regimen (dialysis program, medications, diet, and fluid).
Study NCT06744387 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: clinical assessments and tissue oxygenation monitoring by Near Infrared Spectroscopy
Description: Flap failure will be identified, based upon gold standard monitoring (flaps skin color, temperature, tissue turgor and capillary refill time) along with Doppler technique during a postoperative period of seven days. In all patients Near Infrared Spectroscopy (NIRS) by FORE-SIGHT ELITE will be applied to obtain continuous tissue oxygenation measurements. NIRS values and trends from patients with flap failure (case group) will be compared to NIRS values and trends from patients with no flap failure(control group).
Study NCT06744465 — intervention group
Intervention type: DEVICE
Intervention: NearWave monitoring
Description: NearWave optical molecular monitoring